Revelation Biosciences, Inc. (REVB) Stock Price History
Historical prices from 2020 to 2026
Loading 10-year price history...
REVB Historical Performance
Short-Term Returns
REVB Stock Price Trajectory (2020–2026)
As of May 8, 2026, Revelation Biosciences, Inc. (REVB) trades at $1.02, representing a -97.1% return over the past year. The stock has delivered a -100.0% total return over five years (-93.1% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $999,999.00 on January 19, 2022. From this peak, REVB has corrected -100.0%, currently trading 77% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers ADMA (-64.1% 1Y), AGEN (+27.1% 1Y), and IMVT (+96.1% 1Y), REVB has underperformed the peer group average. Compare REVB vs ADMA →
REVB Historical Price Data (2025–2026)
Showing 30 of 1,374 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 1.05 | 1.06 | 1.00 | 1.02 | 54K | 0.00% |
| 2026-05-06 | 1.02 | 1.07 | 1.02 | 1.02 | 98K | -4.67% |
| 2026-05-05 | 1.08 | 1.10 | 1.05 | 1.07 | 48K | -0.93% |
| 2026-05-04 | 1.10 | 1.12 | 1.04 | 1.08 | 72K | -3.57% |
| 2026-05-01 | 1.10 | 1.12 | 1.10 | 1.12 | 28K | -0.88% |
| 2026-04-30 | 1.14 | 1.17 | 1.09 | 1.13 | 51K | -1.74% |
| 2026-04-29 | 1.18 | 1.18 | 1.14 | 1.15 | 42K | -0.86% |
| 2026-04-28 | 1.18 | 1.18 | 1.14 | 1.16 | 19K | +0.87% |
| 2026-04-27 | 1.15 | 1.18 | 1.14 | 1.15 | 21K | -1.71% |
| 2026-04-24 | 1.17 | 1.18 | 1.15 | 1.17 | 28K | +0.86% |
| 2026-04-23 | 1.18 | 1.19 | 1.13 | 1.16 | 73K | 0.00% |
| 2026-04-22 | 1.17 | 1.18 | 1.16 | 1.16 | 18K | 0.00% |
| 2026-04-21 | 1.18 | 1.28 | 1.16 | 1.16 | 76K | 0.00% |
| 2026-04-20 | 1.15 | 1.17 | 1.11 | 1.16 | 113K | +1.31% |
| 2026-04-17 | 1.18 | 1.21 | 0.99 | 1.15 | 427K | -4.58% |
| 2026-04-16 | 1.25 | 1.30 | 1.20 | 1.20 | 118K | -4.76% |
| 2026-04-15 | 1.21 | 1.27 | 1.19 | 1.26 | 59K | +5.00% |
| 2026-04-14 | 1.22 | 1.23 | 1.20 | 1.20 | 43K | +0.84% |
| 2026-04-13 | 1.19 | 1.21 | 1.17 | 1.19 | 24K | +1.71% |
| 2026-04-10 | 1.23 | 1.25 | 1.14 | 1.17 | 94K | -4.88% |
| 2026-04-09 | 1.22 | 1.28 | 1.19 | 1.23 | 62K | +1.65% |
| 2026-04-08 | 1.20 | 1.26 | 1.13 | 1.21 | 110K | +7.08% |
| 2026-04-07 | 1.15 | 1.17 | 1.10 | 1.13 | 36K | -2.59% |
| 2026-04-06 | 1.14 | 1.19 | 1.12 | 1.16 | 133K | -7.20% |
| 2026-04-02 | 1.20 | 1.25 | 1.20 | 1.25 | 50K | +1.63% |
| 2026-04-01 | 1.23 | 1.23 | 1.18 | 1.23 | 42K | +2.50% |
| 2026-03-31 | 1.23 | 1.23 | 1.20 | 1.20 | 112K | +0.84% |
| 2026-03-30 | 1.11 | 1.22 | 1.06 | 1.19 | 207K | +5.31% |
| 2026-03-27 | 1.13 | 1.17 | 1.11 | 1.13 | 34K | 0.00% |
| 2026-03-26 | 1.18 | 1.19 | 1.12 | 1.13 | 28K | -4.24% |
See REVB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs REVB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare REVB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonREVB — Frequently Asked Questions
Quick answers to the most common questions about buying REVB stock.
How has REVB stock performed recently?
REVB declined -97.1% over the past year, below its 5-year annualized CAGR of -93.1%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is REVB's all-time high price?
Revelation Biosciences, Inc. reached $999999.00 on 2022-01-19. The 52-week high is $40.08. Current 1-year return of -97.1% places the stock further from historical peaks.
Where can I download REVB historical price data?
This page provides REVB daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2020-2026, downloadable in CSV format.